Association with the nonparoxysmal atrial fibrillation duration and outcome of ExTRa Mapping-guided rotor ablation.

Yusuke OkuyamaTomoya OzawaTakuma NishikawaYusuke FujiiKoichi KatoYoshihisa SugimotoYoshihisa NakagawaTakashi Ashihara

Published in: Journal of arrhythmia (2023)

A non-PAF duration of ≤60 months prior to ExTRa-ABL was associated with a better outcome. The effect of ExTRa-ABL was considered to be limited in patients with >60 months of non-PAF duration.

Keyphrases

atrial fibrillation
tyrosine kinase
catheter ablation
chronic myeloid leukemia
high resolution
left atrial appendage
oral anticoagulants
direct oral anticoagulants